Search Results - BULLOCK, Susie

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Phase I Study of SS1P, a Recombinant Anti-Mesothelin Immunotoxin Given as a Bolus I.V. Infusion to Patients with Mesothelin-Expressing Mesothelioma, Ovarian, and Pancreatic Cancers

    Phase I Study of SS1P, a Recombinant Anti-Mesothelin Immunotoxin Given as a Bolus I.V. Infusion to Patients with Mesothelin-Expressing Mesothelioma, Ovarian, and Pancreatic Cancers by HASSAN, Raffit, BULLOCK, Susie, PREMKUMAR, Ahalya, KREITMAN, Robert J, KINDLER, Hedy, WILLINGHAM, Mark C, PASTAN, Ira

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Biomarker testing and tissue journey among patients with metastatic non-small cell lung cancer receiving first-line therapy in The US Oncology Network

    Biomarker testing and tissue journey among patients with metastatic non-small cell lung cancer receiving first-line therapy in The US Oncology Network by Robert, Nicholas J., Espirito, Janet L., Chen, Liwei, Nwokeji, Esmond, Karhade, Mandar, Evangelist, Makenzi, Spira, Alexander, Neubauer, Marcus, Bullock, Susie, Walberg, Jennifer, Cheng, Steven K., Coleman, Robert L.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Activity of Combination Chemotherapy, Docetaxel and Epirubicin as Neoadjuvant Therapy for Women with Breast Cancer

    Activity of Combination Chemotherapy, Docetaxel and Epirubicin as Neoadjuvant Therapy for Women with Breast Cancer by TFAYLI, Arafat, HOLTER, Jennifer, BOVA, Abby, VENKATAPPA, Siddhartha, BULLOCK, Susie, DOOLEY, William, OZER, Howard

    Published in Anticancer research
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial

    Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial by Fogelman, David, Jafari, Mehrdad, Varadhachary, Gauri R., Xiong, Henry, Bullock, Susie, Ozer, Harold, Lin, E., Morris, Jeffrey, Cunningham, Patti, Bennett, Bronwyn, Abbruzzese, James L., Wolff, Robert A.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Impact of an Oncology Clinical Pharmacist Intervention on Clinical Trial Enrollment in The US Oncology Network’s MYLUNG Consortium

    Impact of an Oncology Clinical Pharmacist Intervention on Clinical Trial Enrollment in The US Oncology Network’s MYLUNG Consortium by Koselke, PharmD, BCOP, Elizabeth, C. Kaspin-Powell, PhD, Lisa, Hough, PharmD, BCOP, Shannon, Howell, PharmD, BCOP, Joshua, J. Robert, MD, Nicholas, A. Neubauer, MD, Marcus, A. Bullock, DNP, MPH, RN, OCN®, CCRP, Susie, M. Walberg, MPH, Jennifer, Rammage, PharmD, MS, BCOP, Melissa, E. Butrynksi, MD, James, Hakimian, MD, David, M. Jotte, MD, PhD, Robert, W. Meshad, MD, Michael, Ali, MD, Kashif, Michael Waterhouse, MD, MPH, David, L. Coleman, MD, FACOG, FACS, Robert, Colleen Evangelist, MD, Makenzi

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    influence of foundational and expressed values on personal behaviors of teachers

    influence of foundational and expressed values on personal behaviors of teachers by Haygood, J, Baker, M, Hogg, J, Bullock, S

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: